503 related articles for article (PubMed ID: 24056055)
1. The clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkle.
Sherif S; Bendas ER; Badawy S
Eur J Pharm Biopharm; 2014 Feb; 86(2):251-9. PubMed ID: 24056055
[TBL] [Abstract][Full Text] [Related]
2. Development and characterisation of modified poloxamer 407 thermoresponsive depot systems containing cubosomes.
Kojarunchitt T; Hook S; Rizwan S; Rades T; Baldursdottir S
Int J Pharm; 2011 Apr; 408(1-2):20-6. PubMed ID: 21272624
[TBL] [Abstract][Full Text] [Related]
3. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
Kojarunchitt T; Baldursdottir S; Dong YD; Boyd BJ; Rades T; Hook S
Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
[TBL] [Abstract][Full Text] [Related]
4. Nanostructured Cubosomes in a Thermoresponsive Depot System: An Alternative Approach for the Controlled Delivery of Docetaxel.
Rarokar NR; Saoji SD; Raut NA; Taksande JB; Khedekar PB; Dave VS
AAPS PharmSciTech; 2016 Apr; 17(2):436-45. PubMed ID: 26208439
[TBL] [Abstract][Full Text] [Related]
5. Characterization of gelation process and drug release profile of thermosensitive liquid lecithin/poloxamer 407 based gels as carriers for percutaneous delivery of ibuprofen.
Djekic L; Krajisnik D; Martinovic M; Djordjevic D; Primorac M
Int J Pharm; 2015 Jul; 490(1-2):180-9. PubMed ID: 26002567
[TBL] [Abstract][Full Text] [Related]
6. Revisiting β-casein as a stabilizer for lipid liquid crystalline nanostructured particles.
Zhai J; Waddington L; Wooster TJ; Aguilar MI; Boyd BJ
Langmuir; 2011 Dec; 27(24):14757-66. PubMed ID: 22026367
[TBL] [Abstract][Full Text] [Related]
7. Assessment of cubosomal alpha lipoic acid gel efficacy for the aging face: a single-blinded, placebo-controlled, right-left comparative clinical study.
El-Komy M; Shalaby S; Hegazy R; Abdel Hay R; Sherif S; Bendas E
J Cosmet Dermatol; 2017 Sep; 16(3):358-363. PubMed ID: 27873449
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels.
He W; Guo X; Feng M; Mao N
Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520
[TBL] [Abstract][Full Text] [Related]
9. Topical Delivery of Erythromycin Through Cubosomes for Acne.
Khan S; Jain P; Jain S; Jain R; Bhargava S; Jain A
Pharm Nanotechnol; 2018; 6(1):38-47. PubMed ID: 29424323
[TBL] [Abstract][Full Text] [Related]
10. Disposition and association of the steric stabilizer Pluronic® F127 in lyotropic liquid crystalline nanostructured particle dispersions.
Tilley AJ; Drummond CJ; Boyd BJ
J Colloid Interface Sci; 2013 Feb; 392():288-296. PubMed ID: 23137909
[TBL] [Abstract][Full Text] [Related]
11. Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulation.
Cafaggi S; Russo E; Caviglioli G; Parodi B; Stefani R; Sillo G; Leardi R; Bignardi G
Eur J Pharm Sci; 2008 Sep; 35(1-2):19-29. PubMed ID: 18598763
[TBL] [Abstract][Full Text] [Related]
12. Thermoreversible in situ gelling poloxamer-based systems with chitosan nanocomplexes for prolonged subcutaneous delivery of heparin: design and in vitro evaluation.
Radivojša M; Grabnar I; Ahlin Grabnar P
Eur J Pharm Sci; 2013 Sep; 50(1):93-101. PubMed ID: 23524253
[TBL] [Abstract][Full Text] [Related]
13. Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavity.
Jones DS; Bruschi ML; de Freitas O; Gremião MP; Lara EH; Andrews GP
Int J Pharm; 2009 May; 372(1-2):49-58. PubMed ID: 19429268
[TBL] [Abstract][Full Text] [Related]
14. Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz.
Avachat AM; Parpani SS
Colloids Surf B Biointerfaces; 2015 Feb; 126():87-97. PubMed ID: 25543986
[TBL] [Abstract][Full Text] [Related]
15. D-Optimal Design in the Development of Rheologically Improved In Situ Forming Ophthalmic Gel.
Krtalić I; Radošević S; Hafner A; Grassi M; Nenadić M; Cetina-Čižmek B; Filipović-Grčić J; Pepić I; Lovrić J
J Pharm Sci; 2018 Jun; 107(6):1562-1571. PubMed ID: 29421217
[TBL] [Abstract][Full Text] [Related]
16. Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines.
Rizwan SB; Assmus D; Boehnke A; Hanley T; Boyd BJ; Rades T; Hook S
Eur J Pharm Biopharm; 2011 Sep; 79(1):15-22. PubMed ID: 21237267
[TBL] [Abstract][Full Text] [Related]
17. Cubosomal Betamethasone-Salicylic Acid Nano Drug Delivery System for Enhanced Management of Scalp Psoriasis.
Shalaby RA; El-Gazayerly O; Abdallah M
Int J Nanomedicine; 2022; 17():1659-1677. PubMed ID: 35444415
[TBL] [Abstract][Full Text] [Related]
18. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
[TBL] [Abstract][Full Text] [Related]
19. Silica nanoparticle stabilization of liquid crystalline lipid dispersions: impact on enzymatic digestion and drug solubilization.
Bhatt AB; Barnes TJ; Prestidge CA
Curr Drug Deliv; 2015; 12(1):47-55. PubMed ID: 25176029
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin.
Peng X; Zhou Y; Han K; Qin L; Dian L; Li G; Pan X; Wu C
Drug Des Devel Ther; 2015; 9():4209-18. PubMed ID: 26345516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
